Predicted to enable CD4 receptor binding activity; enzyme binding activity; and phospholipid scramblase activity. Predicted to be involved in cellular response to lipopolysaccharide and plasma membrane phospholipid scrambling. Predicted to be active in plasma membrane. Orthologous to human PLSCR4 (phospholipid scramblase 4); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3,3',4,4',5-pentachlorobiphenyl; aflatoxin B1.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLSCR4 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLSCR4 mRNA
[Disulfiram binds to Copper] which results in increased expression of PLSCR4 mRNA and [NSC 689534 binds to Copper] which results in increased expression of PLSCR4 mRNA
[Disulfiram binds to Copper] which results in increased expression of PLSCR4 mRNA and [NSC 689534 binds to Copper] which results in increased expression of PLSCR4 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLSCR4 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLSCR4 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLSCR4 mRNA
[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLSCR4 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLSCR4 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLSCR4 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLSCR4 mRNA